Xlife Sciences AG (SWX:XLS)

Switzerland · Delayed Price · Currency is CHF

21.40

0.00 (0.00%)

Last updated: Feb 20, 2026, 9:26 AM CET

Revenue by Segment

Financials in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Technology Platforms	150.42K	-	-	-	-
Unallocated	684.46K	652.30K	748.13K	711.65K	396.81K
Unallocated Growth	4.93%	-12.81%	5.13%	79.34%	-
Biotechnologies/Therapies	-	336.13K	279.85K	113.33K	-
Biotechnologies/Therapies Growth	-	20.11%	146.93%	-	-
Total	834.88K	988.44K	1.03M	824.98K	396.81K
Total Growth	-15.54%	-3.85%	24.61%	107.90%	-22.92%

Revenue by Geography

Financials in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Switzerland	834.88K	988.44K	1.03M	806.07K	396.81K
Switzerland Growth	-15.54%	-3.85%	27.53%	103.14%	-22.92%
Total	834.88K	988.44K	1.03M	806.07K	396.81K
Total Growth	-15.54%	-3.85%	27.53%	103.14%	-22.92%

Source: S&P Global Market Intelligence.